Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells: Nuclear translocation of the RelA transcription factor as a mechanism producing airway mucosal inflammation

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 8773-8781

  Garofalo, Roberto ^a   Sabry, Mona ^a   Jamaluddin, Mohammad ^a   Yu, Robert K ^a   Casola, Antonella ^a   Ogra, Pearay L ^a   Brasier, Allan R ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; VIRUS INFECTION;

EID: 0029911395     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.8773-8781.1996     Document Type: Article

References (60)

1. Aherne, W. T., T. Bird, S. D. B. Court, P. S. Gardner, and J. McQuillin. 1970. Pathological changes in virus infections of the lower respiratory tract in children. J. Clin. Pathol. 23:7-18.
2. Arnold, R., B. Humbert, H. Werchaus, H. Gallati, and W. Konig. 1994. Interleukin-8, interleukin-6, and soluble tumor necrosis factor receptor type I released from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 82:126-133.
3. Baeuerle, P. A. 1991. The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. Biochim. Biophys. Acta 1072:63-80.
4. Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. S. Baldwin, Jr. 1992. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev. 6:1899-1913.
5. Bennett, C. R. J., and D. Hanire. 1962. Growth and serological characteristics of respiratory syncytial virus. J. Infect. Dis. 110:8-16.
6. Brasier, A. R., J. Li, and K. A. Wimbish. 1996. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. J. Hypertens. 27:1009-1017.
7. Brasier, A. R., and D. Ron. 1991. Use of firefly luciferase reporter gene to study angiotensinogen acute phase response element. Neurosci. 5:108-123.
8. Brasier, A. R., D. Ron, J. E. Tate, and J. F. Habener. 1990. A family of constitutive C/EBP-like DNA binding proteins attenuate the IL-1 alpha induced, NF kappa B mediated trans-activation of the angiotensinogen gene acute-phase response element. EMBO J. 9:3933-3944.
9. Brasier, A. R., J. E. Tate, and J. F. Habener. 1989. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. BioTechniques 7:1116-1122.
10. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκB-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
11. Chaturvedi, M. M., R. LaPushin, and B. B. Aggarwal. 1994. Tumor necrosis factor and lymphotoxin. J. Biol. Chem. 269:14575-14583.
12. Chen, J. Z., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862.
13. Choi, A. M. K., and D. B, Jacoby. 1992. Influenza virus A infection induces interleukin-8 gene expression in human airway epithelial cells. FEBS Lett. 309:327-329.
14. Chonmaitree, T., T. Uchida, M. J. Owen, J. A. Patel, R. Garofalo, T. Sim, and V. M. Howie. Role of leukotriene B4 and interleukin-8 in acute bacterial and viral otitis media. Ann. Otol. Rhinol. Laryngol., in press.
15. Collart, M. A., P. Baeuerle, and P. Vassalli. 1990. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10:1498-1506.
16. Dunn, S. M., L. S. Coles, R. K. Lang, S. Gerondakis, M. A. Vadas, and M. F. Shannon. 1994. Requirement for nuclear factor (NF)-κB p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter. Blood 83:2469-2479.
17. Everard, M. L., A. Swarbrick, M. Wrightham, J. McIntyre, C. Dunkley, P. D. James, H. F. Sewell, and A. D. Milner. 1994. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch. Dis. Child. 71:428-432.
18. Fiedler, M. A., K. Wernke-Dollries, and J. M. Stark. 1995. Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells. Am. J. Physiol. 269:L865-L872.
19. Garofalo, R., J. L. L. Kimpen, R. C. Welliver, and P. L. Ogra. 1992. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J. Pediatr. 120:28-32.
20. Garofalo, R., and P. L. Ogra. 1996. Mechanisms of mucosal immunopathology in respiratory syncytial virus infection, p. 405-420. In M. Kagnoff and H. Kiyono (ed.), Essentials of mucosal immunology. Academic Press, San Diego, Calif.
21. Garofalo, H., R. C. Welliver, and P. L. Ogra. 1991. Concentrations of LTB4, LTC4, LTD4 and LTE4 in bronchiolitis due to respiratory syncytial virus. Pediatr. Allergy Immunol. 2:30-37.
22. Garoufalis, E., I. Kwan, R. Lin, A. Mustafa, N. Pepin, A. Roulston, J. Lacoste, and J. Hiscott. 1994. Viral induction of the human beta interferon promoter: modulation of transcription by NF-κB/rel proteins and interferon regulatory factors. J. Virol. 68:4707-4715.
23. Glezen, W. P., L. H. Taber, and A. L. Frank. 1986. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child. 140:543-546.
24. Groothuis, J. R., K. M. Gutierre, and B. A. Lauer. 1988. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 82:199-203.
25. Hall, C. B., R. G. Douglas, Jr., K. C. Schnabel, and J. M. Geiman. 1981. Infectivity of respiratory syncytial virus by various routes of inoculation. Infect. Immun. 33:779-783.
26. Hall, C. B., W. J. Hall, and C. L. Gala. 1984. A long term prospective study of children following respiratory syneytial virus infection. J. Pediatr. 105:358-364.
27. Hall, C. B., and C. A. McCarthy. 1995. Respiratory syncytial virus, p. 1501-1519. In G. L. Mandel, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases. Churchill Livingstone, New York.
28. Horton, R. M., Z. Cai, S. N. Ho, and L. R. Pease. 1990. Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. BioTechniques 8:528-535.
29. Jaffray, E., K. M. Wood, and R. T. Hay. 1995. Domain organization of IκBα and sites of interaction with NF-κB p65. Mol. Cell. Biol. 15:2166-2172.
30. Jamaluddin, M., R. Garofalo, P. L. Ogra, and A. R. Brasier. 1996. Inducible translational regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection in pulmonary epithelial cells. J. Virol. 70:1554-1563.
31. Kernen, P., M. P. Wymann, V. von Tscharner, D. A. Deranleau, P.-C. Tai, C. J. Spry, C. A. Dahindu, and C. Baggiolini. 1991. Shape changes, exocytosis and cytosolic free calcium changes in stimulated human eosinophils. J. Clin. Invest. 87:2012-2017.
32. Kisch, A. L., and K. M. Johnson. 1963. A plaque assay for respiratory syncytial virus. Proc. Soc. Exp. Med. Biol. 112:583.
33. Kunsch, C., S. M. Ruben, and C. A. Rosen. 1992. Selection of optimal κB/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:4412-4421.
34. Levine, S. J., P. Larivee, C. Logun, C. W. Angus, and J. H. Shelhamer. 1993. Corticosteroids differentially regulate secretion of IL-6, IL-8 and G-CSF by a human bronchial epithelial cell line. Am. J. Physiol. 265:L360-L368.
35. Li, J., and A. R. Brasier. 1996. Angiotensinogen gene activation by All is mediated by the Rel A (NF-κB p65) transcription factor: one mechanism for the renin angiotensin system (RAS) positive feedback loop in hepatocytes. Mol. Endocrinol. 10:252-264.
36. MacDonald, N. E., C. B. Hall, and S. C. Suffin. 1982. Respiratory syncytial viral infection in infants with congenital heart disease. N. Engl. J. Med. 307: 397-400.
37. Mahajan, P., and E. A. J. Thompson. 1987. Cyclosporin A inhibits rDNA transcription in lymphosarcoma P1798 cells. J. Biol. Chem. 262:16150-16156.
38. Massion, P. P., H. Inoue, J. Richman-Eisenstat, D. Grunberger, P. G. Jorens, B. Houssrt, and J.-F. Pittet. 1994. Novel pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J. Clin. Invest. 93:26-32.
39. Mastronarde, J. G., B. He, M. M. Monick, N. Mukaida, K. Matsushima, and G. W. Hunninghake. 1996. Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-κB and NF-IL-6. J. Infect. Dis. 174:262-267.
40. Nakamura, H., K. Yoshimura, H. A. Jaffe, and R. G. Crystal. 1991. Interleukin-8 gene expression in human bronchial epithelial cells. J. Biol. Chem. 266:19611-19617.
41. Noah, T. L., and S. Becker. 1993. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am. J. Physiol. 265:L472-L478.
42. Noah, T. L., F. W. Henderson, I. A. Wortman, R. B. Devlin, J. Handy, H. S. Koren, and S. Becker. 1995. Nasal cytokine production in virus acute upper respiratory infection of childhood. J. Infect. Dis. 171:584-592.
43. Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. USA 86: 2336-2340.
44. Patel, J. A., M. Kunimoto, T. C. Sim, R. Garofalo, T. Eliott, S. Baron, O. Ruuskanen, T. Chonmaitree, P. L. Ogra, and F. C. Schmalstieg, Jr. 1995. IL-1α mediates enhanced expression of ICAM-1 in pulmonary epithelial cells infected with respiratory syncytial virus. Am. J. Respir, Cell. Mol. Biol. 13:602-609.
45. Riviere, Y., V. Blank, P. kourilsky, and A. Israel. 1991. Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection. Nature (London) 350:625-626.
46. Ron, D., A. R. Brasier, K. A. Wright, J. E. Tate, and J. F. Habener. 1990. An inducible 50-kilodalton NFκB-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen gene. Mol. Cell. Biol. 10:1023-1032.
47. Roulston, A., P. Beauparlant, N. Rice, and J. Hiscott. 1993. Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-κB/rel DNA binding activities in myelomonoblastic cells. J. Virol. 67:5235-5246.
48. Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:2247-2258.
49. Shahrabadi, M. S., and P. W. K. Lee. 1988. Calcium requirement for syncytium formation in Hep-2 cells by respiratory syncytial virus. J. Clin. Microbiol. 26:139-141.
50. Shen, Q. 1995. Identification of tumor necrosis factor-inducible transcriptional factor(s) binding sites on human interleukin-8 gene promoter. M.S. thesis. University of Texas Medical Branch, Galveston.
51. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405-455.
52. Sly, P. D., and M. D. Hibbert. 1989. Childhood asthma following hospitalization with acute viral bronchiolitis in infancy. Pediatr. Pulmonol. 7:153-158.
53. Standiford, T. J., S. L. Kunkel, M. A. Basha, S. W. Chensue, J. P. I. Lynch, G. B. Toews, J. Westwick, and R. M. Stricter. 1990. Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J. Clin. Invest. 86:1945-1953.
54. Stein, B., and A. S. Baldwin, Jr. 1993. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-κB. Mol. Cell. Biol. 13:7191-7198.
55. Thanos, D., and T. Maniatis. 1995. NF-κB: a lesson in family values. Cell 80:529-532.
56. Ueba, O. 1978. Respiratory syncytial virus. I. Concentration and purification of the infectious virus. Acta Med. Okayama 32:265-272.
57. Visvanathan, K. B., and S. Goodbourn. 1989. Double stranded RNA activates binding of NF-κB to an inducible element in the human κ-interferon promoter. EMBO J. 8:1129-1138.
58. Welliver, R. C., D. T. Wong, M. Sun, E. J. Middleton, R. S. Vaughan, and P. L. Ogra. 1981. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N. Engl. J. Med. 305:841-846.
59. Yasumoto, K., S. Okamoto, N. Mukaida, S. Murakami, M. Mai, and K. Matsushima. 1992. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene. J. Biol. Chem. 267:22506-22511.
60. Zhu, Z., W. Tang, A. Ray, Y. Wu, O. Einarsson, M. L. Landry, J. J. Gwaltney, and J. A. Elias. 1996. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor κB-dependent transcriptional activation. J. Clin. Invest. 97:421-430.